Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

106
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
106
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

4.3K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.3K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

222
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
222
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

5.1K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
5.1K
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

501
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
501

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endoscopic ultrasound-guided gastroenterostomy for the palliation of patients with malignant gastric outlet obstruction: stent dysfunction at the end of life.

Gastrointestinal endoscopy·2026
Same author

Correlations between IgG4-related disease, autoimmune pancreatitis, and allergic diseases.

Frontiers in immunology·2026
Same author

Mitogenomic sequencing of the Brazilian Mastiff and Brazilian Terrier suggests a complex scenario of breed formation for two established Brazilian dog breeds.

Genetics and molecular biology·2026
Same author

Etoricoxib-Induced Fixed Erythema.

Journal of clinical medicine·2025
Same author

Pancreatic steatosis and post-operative pancreatic fistula after pancreatectomy.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

Dapagliflozin restores odour-induced functional integration of primary olfactory cortex circuit but not olfactory-related regional brain activation in patients with type 2 diabetes: A 16-week randomised comparative study.

Diabetes, obesity & metabolism·2025

Related Experiment Video

Updated: Nov 13, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.2K

Clostridioides difficile infection: a comprehensive review for primary providers.

Pedro Cortés1, Yan Bi2, Fernando Stancampiano1

  • 1Division of Community Internal Medicine, Mayo Clinic, Jacksonville, FL, 32224.

Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne
|March 13, 2021
PubMed
Summary

Clostridioides difficile infection (CDI) is a growing concern. This review covers updated CDI diagnosis, treatment, and new therapies for primary care practitioners.

Keywords:
Clostridioides difficileeradicationfecal microbiota transplantationrecurrent infection

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.9K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.4K

Related Experiment Videos

Last Updated: Nov 13, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.2K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.9K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.4K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Clostridioides difficile infection (CDI) presents significant challenges due to increasing incidence, recurrence rates, and associated morbidity.
  • The economic burden of CDI on healthcare systems is substantial and rising.
  • Evolving treatment landscapes necessitate updated clinical guidance.

Purpose of the Study:

  • To provide primary care practitioners with a practical overview of the latest Clostridioides difficile infection (CDI) management strategies.
  • To summarize current diagnostic approaches for CDI.
  • To discuss established and emerging therapeutic options for CDI.

Main Methods:

  • This review synthesizes recent literature and clinical practice guidelines.
  • Key updates in diagnostic criteria and therapeutic recommendations are highlighted.
  • Emerging treatment modalities are examined for their potential clinical utility.

Main Results:

  • Current guidelines emphasize prompt diagnosis and appropriate initial therapy to reduce recurrence.
  • Fecal microbiota transplantation and newer antimicrobial agents represent significant advancements in CDI treatment.
  • Risk stratification aids in tailoring treatment intensity.

Conclusions:

  • Primary care providers play a crucial role in the effective management of Clostridioides difficile infection (CDI).
  • Adherence to updated guidelines and consideration of novel therapies can improve patient outcomes and reduce healthcare costs.
  • Continuous education on CDI is essential for combating this persistent public health threat.